Here, we demonstrate that a single subcutaneous injection of DG9-conjugated PMO (DG9-PMO) ameliorates the severe SMA phenotype in treated SMA mice and extends the life span by enhancing body-wide SMN restoration. Here, SMN2 is linked to proximal spinal muscular atrophy.